T. Rowe Price Associates’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$827K Buy
113,092
+8,130
+8% +$59.5K ﹤0.01% 2069
2025
Q1
$997K Buy
104,962
+13,388
+15% +$127K ﹤0.01% 1958
2024
Q4
$1.51M Sell
91,574
-340,966
-79% -$5.62M ﹤0.01% 1772
2024
Q3
$6.38M Sell
432,540
-156,054
-27% -$2.3M ﹤0.01% 1229
2024
Q2
$8.16M Sell
588,594
-56,898
-9% -$789K ﹤0.01% 1138
2024
Q1
$10.1M Buy
645,492
+4,528
+0.7% +$71.2K ﹤0.01% 1105
2023
Q4
$10.4M Buy
640,964
+46,967
+8% +$760K ﹤0.01% 1082
2023
Q3
$7.31M Buy
593,997
+11,309
+2% +$139K ﹤0.01% 1116
2023
Q2
$9.37M Buy
582,688
+252,988
+77% +$4.07M ﹤0.01% 1084
2023
Q1
$5.74M Buy
329,700
+1,358
+0.4% +$23.6K ﹤0.01% 1153
2022
Q4
$3.03M Sell
328,342
-399,246
-55% -$3.69M ﹤0.01% 1317
2022
Q3
$6.27M Sell
727,588
-844,425
-54% -$7.27M ﹤0.01% 1159
2022
Q2
$12.8M Buy
1,572,013
+5,076
+0.3% +$41.4K ﹤0.01% 1275
2022
Q1
$19M Buy
1,566,937
+16,655
+1% +$202K ﹤0.01% 1233
2021
Q4
$52.9M Sell
1,550,282
-1,220
-0.1% -$41.6K ﹤0.01% 986
2021
Q3
$74.8M Sell
1,551,502
-7,545
-0.5% -$364K 0.01% 873
2021
Q2
$70.4M Buy
1,559,047
+6,811
+0.4% +$308K 0.01% 913
2021
Q1
$74.9M Buy
1,552,236
+189,930
+14% +$9.16M 0.01% 863
2020
Q4
$73.3M Buy
1,362,306
+213,574
+19% +$11.5M 0.01% 826
2020
Q3
$42.4M Buy
1,148,732
+135,118
+13% +$4.98M ﹤0.01% 928
2020
Q2
$31.4M Buy
1,013,614
+74,071
+8% +$2.29M ﹤0.01% 1000
2020
Q1
$25.9M Buy
939,543
+881,841
+1,528% +$24.3M ﹤0.01% 987
2019
Q4
$1.69M Buy
57,702
+38,699
+204% +$1.13M ﹤0.01% 1668
2019
Q3
$363K Buy
19,003
+601
+3% +$11.5K ﹤0.01% 2212
2019
Q2
$404K Buy
18,402
+7,077
+62% +$155K ﹤0.01% 2186
2019
Q1
$232K Buy
11,325
+468
+4% +$9.59K ﹤0.01% 2363
2018
Q4
$137K Buy
10,857
+108
+1% +$1.36K ﹤0.01% 2450
2018
Q3
$165K Buy
10,749
+431
+4% +$6.62K ﹤0.01% 2475
2018
Q2
$135K Buy
10,318
+62
+0.6% +$811 ﹤0.01% 2492
2018
Q1
$84K Buy
10,256
+110
+1% +$901 ﹤0.01% 2496
2017
Q4
$90K Sell
10,146
-4,600
-31% -$40.8K ﹤0.01% 2501
2017
Q3
$164K Hold
14,746
﹤0.01% 2426
2017
Q2
$132K Buy
14,746
+2,100
+17% +$18.8K ﹤0.01% 2451
2017
Q1
$100K Buy
+12,646
New +$100K ﹤0.01% 2488